Bicuspid Aortic Valve (BAV) is a congenital heart condition where the aortic valve has two leaflets instead of the usual three. It is the most common congenital heart defect, affecting approximately 1-2% of the population. BAV is more prevalent in males than females, and it often goes undiagnosed until adulthood. Individuals with BAV are at an increased risk of developing aortic valve stenosis, regurgitation, and other cardiovascular complications. Early detection and regular monitoring are crucial for managing BAV and preventing potential complications.
Bicuspid Aortic Valve (BAV) is a congenital heart condition characterized by the presence of two leaflets instead of the normal three in the aortic valve. It is the most common congenital heart defect, affecting approximately 1-2% of the population. BAV is more prevalent in males than females, with a ratio of about 3:1.
While the exact cause of BAV is not fully understood, it is believed to be a result of genetic factors. Studies have shown that BAV can run in families, suggesting a hereditary component. Additionally, certain genetic syndromes, such as Turner syndrome and Marfan syndrome, are associated with a higher risk of BAV.
BAV can lead to various complications, including aortic valve stenosis (narrowing of the valve opening) or regurgitation (leaking of blood back into the heart). It can also increase the risk of developing aortic aneurysms and other cardiovascular conditions.
Early detection and regular monitoring of BAV are crucial to manage potential complications. Individuals with BAV should undergo periodic echocardiograms and consult with a cardiologist to ensure appropriate care and treatment.